Journal article
A randomized trial of high-flow oxygen therapy in infants with bronchiolitis
D Franklin, FE Babl, LJ Schlapbach, E Oakley, S Craig, J Neutze, J Furyk, JF Fraser, M Jones, JA Whitty, SR Dalziel, A Schibler
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2018
Abstract
BACKGROUND High-flow oxygen therapy through a nasal cannula has been increasingly used in infants with bronchiolitis, despite limited high-quality evidence of its efficacy. The efficacy of high-flow oxygen therapy through a nasal cannula in settings other than intensive care units (ICUs) is unclear. METHODS In this multicenter, randomized, controlled trial, we assigned infants younger than 12 months of age who had bronchiolitis and a need for supplemental oxygen therapy to receive either high-flow oxygen therapy (high-flow group) or standard oxygen therapy (standard-therapy group). Infants in the standard-therapy group could receive rescue high-flow oxygen therapy if their condition met crit..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
Funded by the National Health and Medical Research Council and others. Australian and New Zealand Clinical Trials Registry number, ACTRN12613000388718.